CD274 and non-small cell lung carcinoma: Moreover, it has been demonstrated that PD-L1 expression is driven by constitutive oncogenic signaling pathways in some tumors, such as glioblastomas.21 However, it is unclear whether a specific upstream signaling pathway of PD-L1 independent of immunoinhibitory signals in NSCLC.